Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The role of mitochondrial hexokinase binding in the abnormal energy metabolism of tumor cell lines.

× No keyword cloud information.

8 in total

Review 1. Hexokinase-2 bound to mitochondria: cancer's stygian link to the "Warburg Effect" and a pivotal target for effective therapy.

Authors: Saroj P Mathupala; Young H Ko; Peter L Pedersen
Journal: Semin Cancer Biol Date: 2008-12-03 Impact factor: 15.707

Review 2. The pivotal roles of mitochondria in cancer: Warburg and beyond and encouraging prospects for effective therapies.

Authors: Saroj P Mathupala; Young H Ko; Peter L Pedersen
Journal: Biochim Biophys Acta Date: 2010-04-08

Review 3. Hexokinase-binding properties of the mitochondrial VDAC protein: inhibition by DCCD and location of putative DCCD-binding sites.

Authors: R A Nakashima
Journal: J Bioenerg Biomembr Date: 1989-08 Impact factor: 2.945

4. Photodynamic tumor therapy: mitochondrial benzodiazepine receptors as a therapeutic target.

Authors: A Verma; S L Facchina; D J Hirsch; S Y Song; L F Dillahey; J R Williams; S H Snyder
Journal: Mol Med Date: 1998-01 Impact factor: 6.354

5. Butyrate activates the monocarboxylate transporter MCT4 expression in breast cancer cells and enhances the antitumor activity of 3-bromopyruvate.

Authors: Odília Queirós; Ana Preto; António Pacheco; Céline Pinheiro; João Azevedo-Silva; Roxana Moreira; Madalena Pedro; Young H Ko; Peter L Pedersen; Fátima Baltazar; Margarida Casal
Journal: J Bioenerg Biomembr Date: 2012-02-17 Impact factor: 2.945

The role of mitochondrial hexokinase binding in the abnormal energy metabolism of tumor cell lines.

Review 1. Hexokinase-2 bound to mitochondria: cancer's stygian link to the "Warburg Effect" and a pivotal target for effective therapy.

Review 2. The pivotal roles of mitochondria in cancer: Warburg and beyond and encouraging prospects for effective therapies.

Review 3. Hexokinase-binding properties of the mitochondrial VDAC protein: inhibition by DCCD and location of putative DCCD-binding sites.

4. Photodynamic tumor therapy: mitochondrial benzodiazepine receptors as a therapeutic target.

5. Butyrate activates the monocarboxylate transporter MCT4 expression in breast cancer cells and enhances the antitumor activity of 3-bromopyruvate.

6. Compartmentalization of transport and phosphorylation of glucose in a hepatoma cell line.

7. Antioxidant enzyme activities and oxidative stress in human breast cancer.

8. Identification of a mitochondrial-binding site on the N-terminal end of hexokinase II.